Cargando…
EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747481/ http://dx.doi.org/10.1016/j.jval.2022.09.1025 |
| _version_ | 1784849609320824832 |
|---|---|
| author | Seinfeld, J Sobrevilla, A Rosales, ML Ibañez, M Munayco, C Londono, S |
| author_facet | Seinfeld, J Sobrevilla, A Rosales, ML Ibañez, M Munayco, C Londono, S |
| author_sort | Seinfeld, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9747481 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97474812022-12-14 EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 Seinfeld, J Sobrevilla, A Rosales, ML Ibañez, M Munayco, C Londono, S Value Health Article Published by Elsevier Inc. 2022-12 2022-12-14 /pmc/articles/PMC9747481/ http://dx.doi.org/10.1016/j.jval.2022.09.1025 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Seinfeld, J Sobrevilla, A Rosales, ML Ibañez, M Munayco, C Londono, S EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 |
| title | EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 |
| title_full | EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 |
| title_fullStr | EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 |
| title_full_unstemmed | EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 |
| title_short | EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 |
| title_sort | eph104 valuing the impact of incorporating an acellular hexavalent vaccine in the national vaccination scheme of peru in the context of covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747481/ http://dx.doi.org/10.1016/j.jval.2022.09.1025 |
| work_keys_str_mv | AT seinfeldj eph104valuingtheimpactofincorporatinganacellularhexavalentvaccineinthenationalvaccinationschemeofperuinthecontextofcovid19 AT sobrevillaa eph104valuingtheimpactofincorporatinganacellularhexavalentvaccineinthenationalvaccinationschemeofperuinthecontextofcovid19 AT rosalesml eph104valuingtheimpactofincorporatinganacellularhexavalentvaccineinthenationalvaccinationschemeofperuinthecontextofcovid19 AT ibanezm eph104valuingtheimpactofincorporatinganacellularhexavalentvaccineinthenationalvaccinationschemeofperuinthecontextofcovid19 AT munaycoc eph104valuingtheimpactofincorporatinganacellularhexavalentvaccineinthenationalvaccinationschemeofperuinthecontextofcovid19 AT londonos eph104valuingtheimpactofincorporatinganacellularhexavalentvaccineinthenationalvaccinationschemeofperuinthecontextofcovid19 |